Published • loading... • Updated
Musk's Neuralink gets FDA's breakthrough device tag for 'Blindsight' implant
- Neuralink has received “breakthrough device” clearance from the FDA for its Blindsight implant, which offers priority FDA review but does not confirm a cure for blindness.
- Blindsight is a technology designed to help restore limited vision using microelectrode arrays embedded in the visual cortex.
- Elon Musk claimed that Blindsight could enable those who are blind to see, although experts warn that such claims are premature.
Insights by Ground AI
38 Articles
38 Articles
Coverage Details
Total News Sources38
Leaning Left1Leaning Right5Center5Last UpdatedBias Distribution46% Center, 45% Right
Bias Distribution
- 46% of the sources are Center, 45% of the sources lean Right
46% Center
C 46%
R 45%
Factuality
To view factuality data please Upgrade to Premium

















